Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome-Reference-Cited by-同舟云学术

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

Published:2017-02-14 Issue:5 Volume:32 Page:739-749
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Hill-Burns Erin M.¹,Debelius Justine W.²,Morton James T.³,Wissemann William T.¹,Lewis Matthew R.¹,Wallen Zachary D.¹,Peddada Shyamal D.⁴,Factor Stewart A.⁵,Molho Eric⁶,Zabetian Cyrus P.⁷^ORCID,Knight Rob²³⁸,Payami Haydeh¹⁹

Affiliation:

1. Department of Neurology; University of Alabama at Birmingham; Birmingham Alabama USA

2. Department of Pediatrics; University of California San Diego; La Jolla California USA

3. Department of Computer Science and Engineering; University of California San Diego; La Jolla California USA

4. Biostatistics and Computational Biology Branch; National Institute of Environmental Health Sciences; Research Triangle Park North Carolina USA

5. Department of Neurology; Emory University School of Medicine; Atlanta Georgia USA

6. Department of Neurology; Albany Medical College; Albany New York USA

7. Veterans Affairs Puget Sound Health Care System and Department of Neurology; University of Washington; Seattle Washington USA

8. Center for Microbiome Innovation; University of California San Diego; La Jolla California USA

9. Center for Genomic Medicine; HudsonAlpha Institute for Biotechnology; Huntsville Alabama USA

Funder

National Institute of Neurological Disorders and Stroke

Udall

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference54 articles.

1. Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms;Cersosimo;J Neurol,2013

2. Neuropathological basis of nonmotor manifestations of Parkinson's disease;Adler;Mov Disord,2016

3. Colonic inflammation in Parkinson's disease;Devos;Neurobiol Dis,2013

4. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease;Forsyth;PLoS One,2011

5. Vagotomy and subsequent risk of Parkinson's disease;Svensson;Ann Neurol,2015

Cited by 618 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal metal exposures and childhood gut microbial signatures are associated with depression score in late childhood;Science of The Total Environment;2024-03

2. Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach;Brain, Behavior, and Immunity;2024-03

3. Changes in Bacterial Gut Composition in Parkinson’s Disease and Their Metabolic Contribution to Disease Development: A Gut Community Reconstruction Approach;Microorganisms;2024-02-04

4. Effect of Lycium ruthenicum and Lycium barbarum intake on Parkinson based on microbiology and metabonomics: A randomized pilot trial;Food Bioscience;2024-02

5. Unravelling the mechanisms of underweight in Parkinson’s disease by investigating into the role of gut microbiome;npj Parkinson's Disease;2024-01-24